MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
6. Technology Transfer (T2), NonDilutive Funding: Strategy Development
* T2ToolBox
Triple Helix: Reports, Publications & Metrics
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Ireland
Amarin Corporation plc (NASDAQ: AMRN)*
Organization & Developments: Amarin
Parents
Amarin Corporation plc (NASDAQ: AMRN)*
Children
2020: All Eyes on Vascepa 2020 Sales
2020: Amarin Corp.: Whether Vascepa Is A COVID-19 Play
2020: Amarin Is A Buy Based On Vascepa's Potential In Europe
2020: Amarin loses patent appeal and their brief grip on a cardiovascular, fish oil empire
2020: Amarin spurns would-be marketing partners to launch Vascepa in Europe on its own
2020: Amarin up 3% on new Vascepa data from Reduce-It study
2020: Amarin: 'The Future Ain't What It Used To Be'_Seeking Alpha
2020: Amarin: The Alpha And The Omega_seekingalpha.com
2020: Amarin's Legal Appeal Part I - An Introductory Article Discussing Timeline And Valuation Scenarios
2020: Amarin's Vascepa Is a Great Story Filled With Too Many Unknowns
2020: Generic Vascepa approved; Amarin slides (NASDAQ:AMRN)
2020: Wall Street funds sold Amarin after its big win
2021: Amarin Could Be A Value Pick With An EMA Approval Coming
2021: Amarin Stock Looks Attractive Despite U.S. Litigations
2021: Circling Back On Amarin Again
2022: Amarin Corporation plc 2022 Q3 - Results - Earnings Call Presentation_seekingalpha.com
2022: Amarin, after 33% revenue decline, aims to 'stabilize' US sales and grow in Europe
2022: Amarin: The Question Of A Turnaround_ seekingalpha.com
2022: Amarin's German Troubles And Its Spillover To Other Markets_ seekingalpha.com
2022: With Vascepa sales tanking, Amarin cuts US headcount by 65%, replaces CFO_ fiercepharma
2023: Amarin axes 120 of its 385 employees, hires new CEO Patrick Holt
2024: Amarin: Sarissa Is Giving Me Hope Again_ seekingalpha.com
2025: Amarin Is A Sell Despite The Large Cash Balance
2025: Investor group calls for strategy shift as Amarin shares continue to flounder post-Sarissa Capital takeover
Organization & Developments: Amarin (Archives - 2018 - 2019)
Jumps
*Key People: Amarin
Finance & Acquisitions: Amarin